Open AccessNovel associations between CYP2B6 polymorphisms, perioperative methadone metabolism and clinical outcomes in children
Author(s) -
Senthil Packiasabapathy,
Blessed W Aruldhas,
Pengyue Zhang,
Brian R. Overholser,
Sara K. Quinney,
Senthilkumar Sadhasivam
Publication year - 2021
Publication title -
pharmacogenomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.541
H-Index - 91
eISSN - 1744-8042
pISSN - 1462-2416
DOI - 10.2217/pgs-2021-0039
Subject(s) - methadone , cyp2b6 , medicine , pharmacogenetics , perioperative , anesthesia , prospective cohort study , incidence (geometry) , pharmacology , pharmacokinetics , genotype , metabolism , biology , cyp3a4 , cytochrome p450 , genetics , physics , optics , gene
Aim: Methadone exhibits significant variability in clinical response. This study explores the genetic influence of variable methadone pharmacokinetics. Methods: This is a prospective study of methadone in children undergoing major surgery. CYP2B6 genotyping, plasma methadone and metabolite levels were obtained. Clinical outcomes include pain scores and postoperative nausea and vomiting (PONV). Results: CYP2B6 poor metabolizers (*6/*6) had >twofold lower methadone metabolism compared with normal/rapid metabolizers. The incidence of PONV was 4.7× greater with CYP2B6 rs1038376 variant. AG/GG variants of rs2279343 SNP had 2.86-fold higher incidence of PONV compared with the wild variant ( AA). Nominal associations between rs10500282, rs11882424, rs4803419 and pain scores were observed. Conclusion: We have described novel associations between CYP2B6 genetic variants and perioperative methadone metabolism, and associations with pain scores and PONV.